Considering the two genes for MTHFR, the pharmacogenetic testing report predicted some degree of enzyme deficiency in 74% (n=14) of the patients, being a more severe form of MTHFR deficiency present in 16% (n=3) of the patients. This evidence concerns the gene MTHFR and hyperinsulinemic hypoglycemia, familial, 4.